atrasentan has been researched along with paricalcitol in 2 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (paricalcitol) | Trials (paricalcitol) | Recent Studies (post-2010) (paricalcitol) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 516 | 100 | 288 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delmez, J; Ferder, L; Finch, JL; Liapis, H; Ritter, C; Slatopolsky, E; Suarez, E; Zhang, S | 1 |
| Andress, DL; Bijlsma, MJ; de Zeeuw, D; Heerspink, HJ; Kröpelin, TF; Parving, HH; Persson, F | 1 |
2 other study(ies) available for atrasentan and paricalcitol
| Article | Year |
|---|---|
Cardiac and renal effects of atrasentan in combination with enalapril and paricalcitol in uremic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrasentan; Bone Density Conservation Agents; Drug Therapy, Combination; Enalapril; Endothelin Receptor Antagonists; Ergocalciferols; Female; Glomerulosclerosis, Focal Segmental; Heart; Kidney; Kidney Function Tests; Myocardium; Nephrectomy; Nephritis; Pyrrolidines; Rats; Rats, Sprague-Dawley; Survival Analysis; Uremia | 2014 |
Number and frequency of albuminuria measurements in clinical trials in diabetic nephropathy.
Topics: Aged; Albuminuria; Amides; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrasentan; Bone Density Conservation Agents; Diabetic Nephropathies; Endothelin Receptor Antagonists; Ergocalciferols; Female; Fumarates; Humans; Losartan; Male; Middle Aged; Office Visits; Pyrrolidines; Randomized Controlled Trials as Topic; Research Design; Statistics as Topic; Urine Specimen Collection | 2015 |